omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases
Chelsea X. Alvarado(National Institutes of Health), Hampton L. Leonard(National Institutes of Health), Mathew J. Koretsky(Data Tecnica International (United States)), Mary B. Makarious(National Institutes of Health), Faraz Faghri(National Institute on Aging), Cory A. Weller(National Institutes of Health), Dan Vitale(National Institutes of Health), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Andrew Singleton(Short and Associates (United States)), Kristin Levine(National Institutes of Health), Mike A. Nalls(National Institutes of Health), Sara Bandrés‐Ciga(National Institutes of Health)
Cited by 1
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k